{"mainPropery":{"diseaseId":10758,"diseaseName":"Pseudohypoparathyroidism","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10758/pseudohypoparathyroidism","synonyms":[],"synonyms-with-source":[],"identifiers":[]},"diseaseCategories":[{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases"}],"organizations":[{"resourceID":263,"resourceName":"Hormone Health Network","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"United States","phone":"","tty":"","tollFree":"1-800-HORMONE (1-800-467-6663)","fax":"","email":"hormone@endocrine.org","url":"https://www.hormone.org","freeText":""},{"resourceID":375,"resourceName":"HypoPARAthyroidism Association, Inc.","abbreviation":"HPTH ","address1":"695 Montecito Ct","address2":"","address3":"","address4":"","address5":"","city":"Lemoore","state":"CA","zip":"93245","country":"United States","phone":"+1-559-817-7170","tty":"","tollFree":"","fax":"","email":"dmurphy@hypopara.org","url":"https://hypopara.org/","freeText":""},{"resourceID":2531,"resourceName":"Hypopara UK","abbreviation":"","address1":"6 The Meads ","address2":"East Grinstead","address3":"","address4":"","address5":"","city":"West Sussex","state":"","zip":"RH19 4DF","country":"United Kingdom","phone":"01342 316315","tty":"","tollFree":"","fax":"","email":"lizglenister@hypopara.org.uk","url":"http://hypopara.org.uk/home.php","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/omim?Db=omim&Cmd=DetailsSearch&Term=PSEUDOHYPOPARATHYROIDISM%5BAll+Fields%5D' target='_blank'>The Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=%28%22Pseudohypoparathyroidism/classification%22%5BMesh%5D%20OR%20%22Pseudohypoparathyroidism/diagnosis%22%5BMesh%5D%20OR%20%22Pseudohypoparathyroidism/diet%20therapy%22%5BMesh%5D%20OR%20%22Pseudohypoparathyroidism/drug%20therapy%22%5BMesh%5D%20OR%20%22Pseudohypoparathyroidism/epidemiology%22%5BMesh%5D%20OR%20%22Pseudohypoparathyroidism/surgery%22%5BMesh%5D%20OR%20%22Pseudohypoparathyroidism/therapy%22%5BMesh%5D%29%20AND%20%28English%5Blang%5D%20AND%20%222001/03/05%22%5BPDat%5D%20%3A%20%222011/03/02%22%5BPDat%5D%29&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Pseudohypoparathyroidism. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Pseudohypoparathyroidism%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Pseudohypoparathyroidism. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":541,"resourceId":1298,"resourceName":"pseudohypoparathyroidism","descriptionText":"Mantovani G et al., <a href='http://www.ncbi.nlm.nih.gov/pubmed/20061437 ' target='_blank'>Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients</a>. <em>J Clin Endocrinol Metab</em>. 2010 Feb;95(2):651-8. Epub 2010 Jan 8.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":542,"resourceId":1298,"resourceName":"pseudohypoparathyroidism","descriptionText":"Maeda SS, Fortes EM, Oliveira UM, Borba VC, Lazaretti-Castro M. <a href='http://www.ncbi.nlm.nih.gov/pubmed/17117292 ' target='_blank'>Hypoparathyroidism and pseudohypoparathyroidism</a>. <em>Arq Bras Endocrinol Metabol</em>. 2006 Aug;50(4):664-73. Review. ","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":543,"resourceId":1298,"resourceName":"pseudohypoparathyroidism","descriptionText":"Donghi V et al., <a href='http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740291/ ' target='_blank'>Pseudohypoparathyroidism, an often delayed diagnosis: a case series</a>. <em>Cases J. </em>2009; 2: 6734.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/625/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000364.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/124836-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:4184' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":1813,"questionText":"What is pseudohypoparathyroidism?","answerText":"<strong>Pseudohypoparathyroidism</strong> is&nbsp;a genetic disorder in which the body is unable to respond to&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003690.htm\" style=\"background-color: #ffffff;\" target=\"_blank\">parathyroid hormone</a>. Parathyroid hormone helps control calcium, phosphorous, and vitamin D levels in the bones and blood.&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000385.htm\" target=\"_blank\">Hypoparathyroidism</a>&nbsp;is a similar condition in which the body does not make enough parathyroid hormone instead of not being able to respond to it (as in pseudohypoparathyroidism).[1102]<br />\r\n<br />\r\nThe symptoms of these two conditions are similar and are caused by low calcium levels and high phosphate levels in the blood. This may cause <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001001.htm\" target=\"_blank\">cataracts</a>&nbsp;(clouding of the lens of the eye), dental problems, numbness, seizures, or tetany (muscle twitches and hand and foot spasms). These symptoms are usually first seen in childhood.[1102]<br />\r\n<br />\r\nThere are two different types of pseudohypoparathyroidism, both of which are caused by spelling mistakes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in certain genes. Type&nbsp;1 can be further divided into three sub-types.[1102] Click on the links below for more information on the various types of&nbsp;pseudohypoparathyroidism.<br />\r\n<br />\r\n<a href=\"http://rarediseases.info.nih.gov/GARD/Condition/7486/Pseudohypoparathyroidism_type_1A.aspx\" target=\"_blank\">Pseudohypoparathyroidism type 1A<br />\r\n</a><a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10680/Pseudohypoparathyroidism_type_1B.aspx\" target=\"_blank\">Pseudohypoparathyroidism type 1B<br />\r\n</a><a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10681/Pseudohypoparathyroidism_type_1C.aspx\" target=\"_blank\">Pseudohypoparathyroidism type 1C<br />\r\n</a><a href=\"http://rarediseases.info.nih.gov/GARD/Condition/10682/Pseudohypoparathyroidism_type_2.aspx\" target=\"_blank\">Pseudohypoparathyroidism type 2</a>","dateModified":"2016-01-05T00:00:00"},"basicQuestions":[{"questionId":11473,"questionText":"What causes pseudohypoparathyroidism?","answerText":"Pseudohypoparathyroidism is caused by changes (mutations) in a number of different genes including the <a href=\"https://ghr.nlm.nih.gov/gene/GNAS\"><em>GNAS1</em></a> gene. When this gene is not working correctly, the body is not able to properly respond to parathyroid hormone, which increases the level of phosphorous in the blood and decreases the level of calcium. A mutation in this gene is most often inherited from the affected person&rsquo;s mother, although it can sometimes be inherited from the father.[12825]<br />","dateModified":"2016-12-23T17:10:00","resourceClassificationName":"Cause","references":[{"referenceId":12825,"authors":"Garin I, Mantovani G, Aguirre U, Barlier A, Brix B, Elli FM, Freson K, Grybek V, Izzi B, Linglart A, Perez de Nanclares G, Silve C, Thiele S, and Werner R","articleTitle":"European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study","bookWebsiteJournalTitle":"European Journal of Human Genetics","date":"April 2015","volume":"23(4)","pages":"438-444","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666570/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":11471,"questionText":"How is pseudohypoparathyroidism diagnosed?","answerText":"Pseudohypoparathyroidism can be diagnosed by blood or urine tests to measure the levels of calcium, phosphorous, and parathyroid hormone. If the levels of parathyroid hormone and phosphorous are high and if the levels of calcium or low, this indicates the possibility of pseudohypoparathyroidism. A doctor may wish to confirm the diagnosis through genetic testing for a mutation in the <em><a href=\"https://ghr.nlm.nih.gov/gene/GNAS\" target=\"_blank\">GNAS1</a></em> gene.[12823] &nbsp;<br />","dateModified":"2016-12-23T16:58:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":12823,"authors":"Abraham MR and Khardori R","articleTitle":"Pseudohypoparathyroidism","bookWebsiteJournalTitle":"","date":"December 11, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/124836-overview","authors2":"","placeOfPublication":"","publisher":"Medscape"}]},{"questionId":11472,"questionText":"What is the treatment for pseudohypoparathyroidism?","answerText":"The goal of treatment for pseudohypoparathyroidism is to return the levels of calcium and phosphorous to normal. This can be done by taking calcium supplements to increase the level of calcium in the body. Vitamin D supplements also indirectly work to increase calcium levels in the body because vitamin D improves the absorption of calcium.[12823] The doctors may also recommend a low-phosphate diet or specific medications that bind to phosphate in the blood and reduce the effects. <br />\r\n<br />\r\nBecause people affected with certain types of pseudohypoparathyroidism may be shorter than other people, growth hormone may also be a treatment that allows these individuals to grow taller than they otherwise would.[12824]&nbsp;&nbsp;<br />","dateModified":"2016-12-23T17:02:00","resourceClassificationName":"Treatment","references":[{"referenceId":12823,"authors":"Abraham MR and Khardori R","articleTitle":"Pseudohypoparathyroidism","bookWebsiteJournalTitle":"","date":"December 11, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/124836-overview","authors2":"","placeOfPublication":"","publisher":"Medscape"},{"referenceId":12824,"authors":"Germain-Lee EL","articleTitle":"Short stature, obesity, and growth hormone deficiency in pseudohypoparathyroidism type 1a","bookWebsiteJournalTitle":"Pediatric Endocrinology Reviews","date":"April 2006","volume":"3","pages":"318-327","url":"https://www.ncbi.nlm.nih.gov/pubmed/16675931","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":7486,"relatedDiseaseName":"Pseudohypoparathyroidism type 1A","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10680,"relatedDiseaseName":"Pseudohypoparathyroidism type 1B","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10681,"relatedDiseaseName":"Pseudohypoparathyroidism type 1C","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":10682,"relatedDiseaseName":"Pseudohypoparathyroidism type 2","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Pseudohypoparathyroidism"}